TY - JOUR
T1 - Age-dependent prognostic value of exercise capacity and derivation of fitne-aociated biologic age
AU - Blaha, Michael J.
AU - Hung, Rupert K.
AU - Dardari, Zeina
AU - Feldman, David I.
AU - Whelton, Seamus P.
AU - Nasir, Khurram
AU - Blumenthal, Roger S.
AU - Brawner, Clinton A.
AU - Ehrman, Jonathan K.
AU - Keteyian, Steven J.
AU - Al-Mallah, Mouaz H.
PY - 2016/3
Y1 - 2016/3
N2 - Objective Given the aging population and prevalence of sedentary behaviour in the USA, we investigated the impact of differences in exercise capacity aociated with age on long-term outcomes. We derived fitneaociated 'biologic age' as a tool to encourage positive lifestyle changes. Methods This retrospective cohort study included 57 085 patients without established coronary artery disease or heart failure (median age 53 years, 49% women, 29% black) who underwent clinically-referred treadmill stre testing at the Henry Ford Health System from 1991 to 2009. Patients were followed for 10.4±5 and 5.4±4 years for all-cause mortality and myocardial infarction (MI), respectively. We calculated hazard ratios aociated with exercise capacity by age deciles using Cox regreion models, adjusting for demographic and haemodynamic data, medical history, and medication use. Fitne-aociated 'biologic age' was derived as the chronologic age with equivalent mortality or MI risk. Results There were 6356 deaths and 1646 MIs during follow-up. Exercise capacity declined with increasing age. Higher exercise capacity was strongly aociated with greater survival, with per-MET HR ranging from 0.82 (95% CI 0.78 to 0.86) in patients under 40 years of age, to 0.88 (95% CI 0.87 to 0.90) in those over 70 years of age. Biologic age varied markedly-up to three decades-within each age decile, and was a stronger predictor of mortality (C-statistic 0.81 vs 0.77) and MI (C-statistic 0.72 vs 0.68) than chronologic age. Conclusions Higher exercise capacity remained a powerful predictor of survival despite lower average exercise capacity at older ages, reinforcing its importance in patients of all ages. Fitne-aociated biologic age was a stronger predictor of survival than chronologic age, and may be a useful clinical tool for facilitating patient discuions regarding the impact of exercise capacity on long-term risk.
AB - Objective Given the aging population and prevalence of sedentary behaviour in the USA, we investigated the impact of differences in exercise capacity aociated with age on long-term outcomes. We derived fitneaociated 'biologic age' as a tool to encourage positive lifestyle changes. Methods This retrospective cohort study included 57 085 patients without established coronary artery disease or heart failure (median age 53 years, 49% women, 29% black) who underwent clinically-referred treadmill stre testing at the Henry Ford Health System from 1991 to 2009. Patients were followed for 10.4±5 and 5.4±4 years for all-cause mortality and myocardial infarction (MI), respectively. We calculated hazard ratios aociated with exercise capacity by age deciles using Cox regreion models, adjusting for demographic and haemodynamic data, medical history, and medication use. Fitne-aociated 'biologic age' was derived as the chronologic age with equivalent mortality or MI risk. Results There were 6356 deaths and 1646 MIs during follow-up. Exercise capacity declined with increasing age. Higher exercise capacity was strongly aociated with greater survival, with per-MET HR ranging from 0.82 (95% CI 0.78 to 0.86) in patients under 40 years of age, to 0.88 (95% CI 0.87 to 0.90) in those over 70 years of age. Biologic age varied markedly-up to three decades-within each age decile, and was a stronger predictor of mortality (C-statistic 0.81 vs 0.77) and MI (C-statistic 0.72 vs 0.68) than chronologic age. Conclusions Higher exercise capacity remained a powerful predictor of survival despite lower average exercise capacity at older ages, reinforcing its importance in patients of all ages. Fitne-aociated biologic age was a stronger predictor of survival than chronologic age, and may be a useful clinical tool for facilitating patient discuions regarding the impact of exercise capacity on long-term risk.
UR - http://www.scopus.com/inward/record.url?scp=84960971190&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84960971190&partnerID=8YFLogxK
U2 - 10.1136/heartjnl-2015-308537
DO - 10.1136/heartjnl-2015-308537
M3 - Article
C2 - 26732181
AN - SCOPUS:84960971190
SN - 1355-6037
VL - 102
SP - 431
EP - 437
JO - Heart
JF - Heart
IS - 6
ER -